Hospira Carboplatin I.V. Infusion 450mg/45mL single dose vial

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

carboplatin, Quantity: 10 mg/mL

Disponible depuis:

Hospira Australia Pty Ltd

DCI (Dénomination commune internationale):

Carboplatin

forme pharmaceutique:

Injection, intravenous infusion

Composition:

Excipient Ingredients: water for injections

Mode d'administration:

Intravenous Infusion

Unités en paquet:

1 x 45 mL

classe:

Medicine Listed (Export Only)

Type d'ordonnance:

(S1) This Schedule is intentionally blank

indications thérapeutiques:

Head and neck cancer, small cell lung cancer, testicular cancer, ovarian cancer, uterine cancer, malignant lymphoma, non-small cell lung cancer, breast cancer Used in conjunction with other antineoplastic drugs for the following malignant tumours: Paediatric solid malignant tumours (neuroblastoma/retinoblastoma/ hepatoblastoma/central nervous system neuroblastoma, recurrent or refractory Ewing?s sarcoma family tumours/nephroblastoma)

Descriptif du produit:

Visual Identification: Carboplatin Injection is a clear, colourless or pale yellow liquid.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Licence status A

Date de l'autorisation:

2013-10-09